Table 1 Treatment outcomes determined by fibrosis stage.

Patient No	Genotype	Ishak staging score
		Baseline	12 months
1	1b	4	1
2	1b	2	1
3	1b	6	6
4	ND	4	2
5	1b	4	4
6	1b	4	1
7	3a	6	6
8	1b	6	2
9	1a–1b	1	1
10	1b	6	6
11	1b	2	2
12	1	5	5
13	2a–2c	4	4
14	2a–2c	6	6
15	1a	5	5

HCV genotyping was conducted by specific viral DNA sequencing. Fibrosis stage was estimated using the Ishak‐Kamal index at baseline (0) and 12 months after PFD treatment.

ND, not determined.